Clinical Trial Update: Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating simvastatin as an add-on to interferon-beta-1a for relapsing-remitting multiple sclerosis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED